Rapid Influenza Diagnostics Market Trends

  • Report ID: 5310
  • Published Date: Oct 12, 2023
  • Report Format: PDF, PPT

Rapid Influenza Diagnostics Market Trends

Growth Drivers

  • Escalating Technological Advancements – Rapid molecular testing is a new type of highly sensitive and specific molecular diagnostic test for influenza diagnosis that has emerged in recent years. The ability to identify respiratory viruses has been significantly improved through the use of RT-PCR and nucleic acid labeling detection tests. Furthermore, the fundamental goal of molecular influenza diagnostics is to identify specific known pathogens using NAT. NAT is superior to other existing diagnostic devices in several aspects. They do not impact the survival of the target bacteria and can provide results within a clinically relevant time frame. They are capable of identifying low numbers of all known influenza viruses in clinical samples.
  • Increasing Awareness about the Advantages of Early Diagnosis - Another factor driving the need for rapid diagnostic testing for influenza is the growing understanding of the importance of early identification of viral diseases in the global population. In an effort to reduce or even eliminate disease-related mortality, organizations are implementing initiatives to encourage early detection. Make it important the medical decisions regarding support and treatment are made easier due to early diagnosis, for both patients and medical staff. Receiving a proper diagnosis as soon as possible after recognizing the cognitive symptoms associated with the medical condition has many benefits.


  • Variability in Test Sensitivity and Specificity – The sensitivity and specificity of rapid influenza diagnostic tests can vary depending on the type of test and the virus strain being tested. This can lead to false-positive and false-negative results. This is expected to hamper the market expansion of the rapid influenza diagnostics market in the upcoming time period.
  • High Cost of Development and Commercialization is Set to Restrict Market Expansion in the Future Times.
  • Strict Regulatory Requirements are Expected to Hamper the Market Growth in the Forecast Time Period.

Rapid Influenza Diagnostics Market: Key Insights

Base Year


Forecast Year

2024 – 2036



Base Year Market Size

~USD 10 billion

Forecast Year Market Size

~USD 36 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar

  • Report ID: 5310
  • Published Date: Oct 12, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of influenza and growing research and development are some of the major factors anticipated to drive the growth of the rapid influenza diagnostics market.

The market is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2024-2036.

The major players in the market are of Abbott Laboratories, BD, F. Hoffmann-La Roche Ltd, NeuroLogica Corp., GENERAL ELECTRIC, Quest Diagnostics Incorporated, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.,, and others.

The diagnostic centers segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying